Antibacterial Activity and Mechanism of Action of a Novel Anilinouracil-Fluoroquinolone Hybrid Compound
- 1 January 2007
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 51 (1) , 119-127
Abstract
The anilinouracils (AUs) such as 6-(3-ethyl-4-methylanilino)uracil (EMAU) are a novel class of gram-positive, selective, bactericidal antibacterials which inhibit pol IIIC, the gram-positive-specific replicative DNA polymerase. We have linked various fluoroquinolones (FQs) to the N-3 position of EMAU to generate a variety of AU-FQ “hybrids” offering the potential for targeting two distinct steps in DNA replication. In this study, the properties of a hybrid, “251D,” were compared with those of representative AUs and FQs in a variety of in vitro assays, including pol IIIC and topoisomerase/gyrase enzyme assays, antibacterial, bactericidal, and mammalian cytotoxicity assays. Compound 251D potently inhibited pol IIIC and topoisomerase/gyrase, displayed gram-positive antibacterial potency at least 15 times that of the corresponding AU compound, and as expected, acted selectively on bacterial DNA synthesis. Compound 251D was active against a broad panel of antibiotic-resistant gram-positive pathogens as well as several gram-negative organisms and was also active against both AU- and FQ-resistant gram-positive organisms, demonstrating its capacity for attacking both of its potential targets in the bacterium. 251D also was bactericidal for gram-positive organisms and lacked toxicity in vitro. Although we obtained strains of Staphylococcus aureus resistant to the individual parent compounds, spontaneous resistance to 251D was not observed. We obtained 251D resistance in multiple-passage experiments, but resistance developed at a pace comparable to those for the parent compounds. This class of AU-FQ hybrids provides a promising new pharmacophore with an unusual dual mechanism of action and potent activity against antibiotic-sensitive and -resistant gram-positive pathogens.Keywords
This publication has 42 references indexed in Scilit:
- Hybrid Antibacterials. DNA Polymerase−Topoisomerase InhibitorsJournal of Medicinal Chemistry, 2006
- Synthesis and Antibacterial Activity of 3-Substituted-6-(3-ethyl-4-methylanilino)uracilsJournal of Medicinal Chemistry, 2005
- Biological Characterization of Novel Inhibitors of the Gram-Positive DNA Polymerase IIIC EnzymeAntimicrobial Agents and Chemotherapy, 2005
- Low Frequencies of Resistance among Staphylococcus and Enterococcus Species to the Bactericidal DNA Polymerase Inhibitor N 3 -Hydroxybutyl 6-(3′-Ethyl-4′-Methylanilino) UracilAntimicrobial Agents and Chemotherapy, 2002
- DNA Polymerases of Low-GC Gram-Positive Eubacteria: Identification of the Replication-Specific Enzyme Encoded by dnaEJournal of Bacteriology, 2002
- Selection of Enterococcus faecium strains with stable and unstable resistance to the streptogramin RP 59500 using stepwise in vitro exposureDiagnostic Microbiology and Infectious Disease, 1996
- DNA polymerase III of Mycoplasma pulmonis: isolation and characterization of the enzyme and its structural gene, polCMolecular Microbiology, 1994
- Localization of the exonuclease and polymerase domains of Bacillus subtilis DNA polymerase IIIGene, 1992
- Bacillus subtilis DNA polymerase III: complete sequence, overexpression, and characterization of the polC geneGene, 1991
- Deoxyribonucleotide analogs as inhibitors and substrates of DNA polymerasesPharmacology & Therapeutics, 1990